Fuentes Zapata LLC Announces the Release of “The Remote Marketer’s Toolkit”
Sheds For Less Direct Celebrates 20 Years as America’s Original Nationwide Shed Dealer
NightCafe Studio Leverages Google Cloud to Power AI Art Creation for 25 Million Users with a Four-Person Team
TEN Framework Celebrates One-Year Anniversary as Open-Source Infrastructure for Real-Time Conversational AI Development
Safety Training Seminars Opens New CPR Certification School in San Mateo, CA
DUBLIN–(BUSINESS WIRE)–The “United States Private LTE and 5G Network Market: Prospects, Trends Analysis, Market Size…
“Live from the Smithsonian: Living in the World of Dinosaurs” Class Provides Inside Access to…
BOSTON, May 20, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that…
WINSTON-SALEM, N.C., May 20, 2022 (GLOBE NEWSWIRE) — ProKidney LP (ProKidney), a leading clinical-stage cellular…
Further Expands Board’s Expertise and Gender Diversity Enhances Corporate Governance BOSTON, May 20, 2022 (GLOBE…
HALIFAX, Nova Scotia, May 20, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR)…
ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin (sold…
Positive opinion could expand the role of Cosentyx® (secukinumab) in reducing flare risk in pediatric…
JERSEY CITY, N.J., May 20, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
JUPITER, Fla., May 20, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
VAZALORE Featured in Prominent Publication as Promising Alternative to Current Aspirin Options for Secondary Prevention…
YONKERS, N.Y., May 20, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX) (ContraFect), a late…
SYDNEY, AUSTRALIA, May 20, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
GAITHERSBURG, Md., May 20, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
WATERTOWN, Mass., May 20, 2022 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
Presentation available for on demand download beginning Tuesday May 24, 2022 at 7:00 AM ET…
– PTR-01 was well-tolerated over a four-month treatment period in RDEB patients – Treatment with…
MENLO PARK, Calif. and SINGAPORE, May 20, 2022 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN),…
NEW HAVEN, Conn., May 20, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) — Immuneering Corporation (NASDAQ: IMRX), a biopharmaceutical company…